Investigation of the Anti-human Immunodeficiency Virus Activity of Heteronuclear Bis-isatin Scaffolds Tethered through Propyl and Butyl

被引:4
|
作者
Zhang, Longfei [1 ]
Zhao, Shijia [2 ]
Xu, Zhi [3 ]
Liu, Yi [2 ]
机构
[1] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China
[2] Wuhan Univ Sci & Technol, Coll Chem & Chem Engn, Wuhan 430081, Hubei, Peoples R China
[3] Huanghuai Univ, Coll Chem & Pharmaceut Engn, Zhumadian 463000, Peoples R China
关键词
IN-VITRO; DESIGN; DERIVATIVES;
D O I
10.1002/jhet.3691
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A series of novel heteronuclear bis-isatin scaffolds 6a-j tethered through propyl and butyl were designed, synthesized to investigate the influence of the length of the linker between the two isatin motifs and substituents at the isatin framework on the anti-human immunodeficiency virus (HIV) activity against HIV-1(IIIB) (MT-4 cells) in this paper. The synthesized heteronuclear dimers were characterized by H-1-NMR, C-13-NMR, and HRMS. All bis-isatin scaffolds were active against HIV-1(IIIB) with EC50 values ranging from 10.03 to 95.47 mu M and also showed acceptable cytotoxicity towards MT-4 cells. The structure-activity relationship revealed that the length of the linker has great influence on the activity, and the contribution order was butyl > propyl, demonstrating the longer linker was favorable to the activity.
引用
收藏
页码:2975 / 2979
页数:5
相关论文
共 4 条
  • [1] Synthesis and Anti-Human Immunodeficiency Virus Type 1 Activity of (E)-N-Phenylstyryl-N-alkylacetamide Derivatives
    Cheng, Pi
    Chen, Ji-Jun
    Huang, Ning
    Wang, Rui-Rui
    Zheng, Yong-Tang
    Liang, Yi-Zeng
    MOLECULES, 2009, 14 (09) : 3176 - 3186
  • [2] Anti-Human Immunodeficiency Virus Activity, Cross-Resistance, Cytotoxicity, and Intracellular Pharmacology of the 3′-Azido-2′,3′-Dideoxypurine Nucleosides
    Sluis-Cremer, Nicolas
    Koontz, Dianna
    Bassit, Leda
    Hernandez-Santiago, Brenda I.
    Detorio, Mervi
    Rapp, Kim L.
    Amblard, Franck
    Bondada, Lavanya
    Grier, Jason
    Coats, Steven J.
    Schinazi, Raymond F.
    Mellors, John W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) : 3715 - 3719
  • [3] Anti-Human Immunodeficiency Virus Type 1 Activity of Novel 6-Substituted 1-Benzyl-3-(3,5-Dimethylbenzyl) Uracil Derivatives
    Ordonez, Paula
    Hamasaki, Takayuki
    Isono, Yohei
    Sakakibara, Norikazu
    Ikejiri, Masahiro
    Maruyama, Tokumi
    Baba, Masanori
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2581 - 2589
  • [4] Anti-AIDS agents 84. Synthesis and anti-human immunodeficiency virus (HIV) activity of 2′-monomethyl-4-methyl- and 1′-thia-4-methyl-(3′R,4′R)-3′,4′-di-O-(S)-camphanoyl-(+)-cis-khellactone (DCK) analogs
    Xu, Shi-Qing
    Yan, Xin
    Chen, Ying
    Xia, Peng
    Qian, Keduo
    Yu, Donglei
    Xia, Yi
    Yang, Zheng-Yu
    Morris-Natschke, Susan L.
    Lee, Kuo-Hsiung
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (20) : 7203 - 7211